Skip to main content Back to Top
Advertisement

Topics and Formats

Subscribers receive access to the topics below as well as live CE webinars conducted throughout the year.

Coming Soon

Live from the 2016 Midyear Meeting: Improving Performance on Bundled Payment Initiatives: Pharmacy's Role on the Interdisciplinary Team

December 07, 2016 7-8 p.m. ET
Live from The Midyear!

Cynthia Williams, B.S.Pharm., FASHP
Riverside Health System
Newport News, Virginia

ACPE activity # 0204-0000-16-286-L04-T
1 hour (0.1 CEU)

This activity will provide an overview of the core components of the Centers for Medicare & Medicaid Services (CMS) bundled payment initiative. Learn about opportunities for pharmacy involvement to improve performance on bundled payment initiatives. Medication-related initiatives that have been shown to improve patient outcomes and lower costs in the area of bundled payment initiatives will be highlighted.

Learning Objectives

At the conclusion of this knowledge-based educational activity, participants will be able to
  • Describe the core components of the Centers for Medicare & Medicaid Services (CMS) bundled payment initiative.
  • List three medication-related initiatives that have been shown to improve patient outcomes and lower costs in the area of bundled payment initiatives.
  • Evaluate three opportunities for pharmacy involvement within your organization to improve performance on bundled payment initiatives.
  • Webinar

November 10, 2016 1:00-2:00 p.m., ET

Melanie W. Pound, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Campbell University College of Pharmacy and Health Sciences
New Hanover Regional Medical Center
Wilmington, North Carolina

ACPE activity # 0204-0000-16-464-L01-T
1 hour (0.1 CEU)

This activity will describe the new FDA-approved medications for 2016. Faculty will review the following prescription medications in terms of approved indications and pharmacology:

  • lixisenatide
  • brivaracetam
  • pimavanserin
  • reslizumab
  • daclizumab
  • lifitegrast and two combination hepatitis C medications
  • sofosbuvir/velpatasvir
  • elbasvir/grazoprevir

In addition, common adverse effects and drug interactions will be discussed for these selected prescription products as well as important counseling tips for patients.

Learning Objectives

At the conclusion of this knowledge-based educational activity, participants will be able to

  • Identify the FDA-approved medications for 2016.
  • Explain the indications and pharmacology of the following prescription products:
    • lixisenatide
    • brivaracetam
    • pimavanserin
    • reslizumab
    • daclizumab
    • lifitegrast and two combination hepatitis C medications
    • sofosbuvir/velpatasvir
    • elbasvir/grazoprevir
  • Describe common adverse events and drug interactions associated with these selected FDA-approved medications for 2016.
  • Webinar

For Subscribers, Log In for CE Activities

Understanding the "Ins" of Informatics Interoperability

Chris Urbanski, B.S.Pharm., M.S., FASHP
Director, Core Clinical Applications
Information Services
Indiana University Health
Indianapolis, Indiana

ACPE activity # 0204-0000-16-462-H04-T
1 hour (0.1 CEU)

Pharmacy technicians are increasingly called upon to assist with pharmacy informatics. Understanding the differences between integrated and interfaced systems and how they work to promote interoperability are key to learning how to decipher the world of informatics. The program will conclude with application of interoperable systems and how they can impact workflow and patient safety at the bedside.

Learning Objectives

At the conclusion of this knowledge-based educational activity, participants will be able to

  • Explain the difference between integrated and interfaced systems.
  • Define and discuss types of interoperability.
  • Define the role of pharmacy technicians with informatics and interoperability.
  • On-Demand
  • CE Monograph

For Subscribers, Log In for CE Activities